Back to Search Results

Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.

Diacon Hospital, Bangalore, India. Electronic address: draravind@hotmail.com. Diacon Hospital, Bangalore, India. Electronic address: bhavanasosale@gmail.com. Jothydev's Diabetes Research Centers, Kerala, India. Electronic address: jothydev@gmail.com. Lina Diabetes Center, Mumbai, India. Electronic address: dr_manoj@hotmail.com. Center For Diabetes & Endocrine Care (CDE), Bangalore, India. Electronic address: drsanjaycreddy@yahoo.com. Diabetologist, Diacare, Diabetes Care & Hormone Clinic, Ahmedabad, India. Electronic address: banshisaboo98@gmail.com. Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chairman, National Diabetes, Obesity and Cholesterol Foundation (N-DOC), President, Diabetes Foundation India (DFI), India. Electronic address: anoopmisra@gmail.com.

Diabetes & metabolic syndrome. 2021;(4):102167
Full text from:

Other resources

Abstract

BACKGROUND AND AIMS The COVID-19 pandemic continues to challenge us. Despite several strides in management, steroids remain the mainstay for treating moderate to severe disease and with it arises challenges such as hyperglycemia. The review aims to enhance awareness amongst physicians on steroid use and hyperglycemia. METHODS An advisory document describing various strategies for hyperglycemia management was prepared in the public interest by DiabetesIndia. RESULTS The review provides awareness on steroids and hyperglycemia, adverse outcomes of elevated blood glucose levels and, advice at the time of discharge. CONCLUSIONS The article emphasizes enhancing awareness on effective management of hyperglycemia during COVID-19.

Methodological quality

Publication Type : Review

Metadata

MeSH terms : SARS-CoV-2 ; Steroids